Class information for:
Level 1: TRASTUZUMAB//LAPATINIB//PERTUZUMAB

Basic class information
Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY 2934640
250 3       BREAST CANCER//BREAST//ONCOLOGY 46676
39 2             BREAST CANCER//ONCOLOGY//TRASTUZUMAB 32738
3197 1                   TRASTUZUMAB//LAPATINIB//PERTUZUMAB 2073

Terms with highest relevance score


rank Category termType chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 TRASTUZUMAB authKW 3313280 32% 33% 659
2 LAPATINIB authKW 1840573 13% 45% 270
3 PERTUZUMAB authKW 1116820 6% 64% 115
4 HER2 authKW 782836 18% 14% 379
5 HER2 POSITIVE authKW 744813 4% 58% 84
6 NERATINIB authKW 430397 2% 75% 38
7 METASTATIC BREAST CANCER authKW 306725 9% 11% 183
8 TRASTUZUMAB RESISTANCE authKW 214802 1% 46% 31
9 HER2 POSITIVE METASTATIC BREAST CANCER authKW 213772 1% 94% 15
10 HER2 POSITIVE BREAST CANCER authKW 199414 2% 40% 33

Web of Science journal categories


chi_square_rank Category chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 Oncology 49962 79% 0% 1639
2 Obstetrics & Gynecology 531 6% 0% 116
3 Pharmacology & Pharmacy 435 11% 0% 226
4 Cell Biology 126 6% 0% 127
5 Health Policy & Services 54 1% 0% 23
6 Health Care Sciences & Services 45 1% 0% 30
7 Medicine, General & Internal 38 4% 0% 79
8 Medicine, Research & Experimental 28 3% 0% 55
9 Pathology 4 1% 0% 23
10 Chemistry, Medicinal 2 1% 0% 23

Address terms


chi_square_rank term chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 BREAST MED ONCOL 56643 4% 5% 74
2 MED DEV ONCOL 53199 0% 50% 7
3 JULES BORDET 47903 3% 6% 56
4 MED ONCOL 43282 18% 1% 377
5 BREAST DATA 42096 1% 21% 13
6 ONCOL MED DEV 41374 0% 39% 7
7 ANAT PATOL BIOREN 40535 0% 67% 4
8 ARIZONA ONCOL 40535 0% 67% 4
9 WASHINGTON CANC 34666 1% 10% 22
10 BRUSTZENTRUM NIEDERRHEIN 34202 0% 75% 3

Journals


chi_square_rank term chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 CLINICAL BREAST CANCER 62485 3% 7% 58
2 BREAST CARE 27854 2% 6% 33
3 ONCOLOGIST 18985 3% 2% 54
4 BREAST CANCER RESEARCH AND TREATMENT 18315 5% 1% 95
5 ANNALS OF ONCOLOGY 15098 4% 1% 92
6 BREAST 10661 2% 2% 42
7 JOURNAL OF CLINICAL ONCOLOGY 10070 5% 1% 105
8 BREAST CANCER RESEARCH 7792 2% 2% 34
9 LANCET ONCOLOGY 6038 1% 1% 28
10 CANCER TREATMENT REVIEWS 5064 1% 1% 26

Author Key Words


chi_square_rank term chi_square shrOfCwithTerm shrOfTermInClass termInClass LCSH search Wikipedia search
1 TRASTUZUMAB 3313280 32% 33% 659 Search TRASTUZUMAB Search TRASTUZUMAB
2 LAPATINIB 1840573 13% 45% 270 Search LAPATINIB Search LAPATINIB
3 PERTUZUMAB 1116820 6% 64% 115 Search PERTUZUMAB Search PERTUZUMAB
4 HER2 782836 18% 14% 379 Search HER2 Search HER2
5 HER2 POSITIVE 744813 4% 58% 84 Search HER2+POSITIVE Search HER2+POSITIVE
6 NERATINIB 430397 2% 75% 38 Search NERATINIB Search NERATINIB
7 METASTATIC BREAST CANCER 306725 9% 11% 183 Search METASTATIC+BREAST+CANCER Search METASTATIC+BREAST+CANCER
8 TRASTUZUMAB RESISTANCE 214802 1% 46% 31 Search TRASTUZUMAB+RESISTANCE Search TRASTUZUMAB+RESISTANCE
9 HER2 POSITIVE METASTATIC BREAST CANCER 213772 1% 94% 15 Search HER2+POSITIVE+METASTATIC+BREAST+CANCER Search HER2+POSITIVE+METASTATIC+BREAST+CANCER
10 HER2 POSITIVE BREAST CANCER 199414 2% 40% 33 Search HER2+POSITIVE+BREAST+CANCER Search HER2+POSITIVE+BREAST+CANCER

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.

Classes with closest relation at Level 1


rank cluster_id2 link
1 1360 HER 2 NEU//C ERBB 2//HER2
2 29333 METASTASIS BIOPSY//RECEPTOR CONVERSION//DISCORDANCE
3 28064 TOP2A//TOPOISOMERASE II ALPHA//TOPO2A
4 4102 CARDIOTOXICITY//ANTHRACYCLINES//CARDIO ONCOLOGY
5 17263 BEVACIZUMAB//METASTATIC BREAST CANCER//HER2 NEGATIVE
6 3968 NEUREGULIN//NEUREGULIN 1//ERBB4
7 3925 NEOADJUVANT CHEMOTHERAPY//LOCALLY ADVANCED BREAST CANCER//PATHOLOGICAL COMPLETE RESPONSE
8 12413 ANTIBODY DRUG CONJUGATE//TRASTUZUMAB EMTANSINE//T DM1
9 7207 FULVESTRANT//ENDOCRINE RESISTANCE//ENDOCRINE THERAPY
10 19631 DIMERIZATION ARM//MED HEMATOL ONCOL BIOL CHEM//MOL DRUG DISCOVERY

Go to start page